Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NEURONETICS-INC-44403632/news/NeuroStar-Advanced-Therapy-Receives-FDA-Clearance-as-a-First-Line-Add-On-Treatment-for-Adolescents-46275879/?utm_source=whatsapp&utm_medium=social&utm_campaign=share